These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 72276)

  • 1. Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
    Brackmann HH; Gormsen J
    Lancet; 1977 Oct; 2(8044):933. PubMed ID: 72276
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
    Brackmann HH; Gormsen J
    Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on Brackmann and Gormsen (Lancet 1977; ii: 933): Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
    Lee CA
    Haemophilia; 2010 May; 16(102):4-5. PubMed ID: 20536981
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.
    Lowe GD; Harvie A; Forbes CD; Prentice CR
    Br Med J; 1976 Nov; 2(6044):1110-1. PubMed ID: 990791
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated F IX concentrate (FEIBA).
    Stenbjerg S; Jorgensen J
    Scand J Haematol; 1977 May; 18(5):421-6. PubMed ID: 877518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience from the Hemophilia Clinic. 3. Intramuscular hemorrhages in hemophilia].
    van Creveld S; Mochtar IA; van Donk H
    Ned Tijdschr Geneeskd; 1970 Apr; 114(17):719-22. PubMed ID: 5444639
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors.
    Hilgartner MW; Knatterud GL
    Blood; 1983 Jan; 61(1):36-40. PubMed ID: 6401216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII and factor IX concentrates in surgery in hemophilia.
    Wolman IJ
    JAMA; 1971 Feb; 215(8):1328. PubMed ID: 5107574
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII.
    Koyama T; Nagao T; Tsunozaki H; Arai M; Miura O
    Pathophysiol Haemost Thromb; 2006; 35(5):405-7. PubMed ID: 17230044
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bilateral prosthesis of the knee in a hemophilia A patient with an inhibitor].
    Lauroua P; Barbier F; Dieu P; Dumora D; Moulinier J
    Ann Fr Anesth Reanim; 1986; 5(2):154-6. PubMed ID: 3089078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Hepatitis E Virus infection in a hemophilic patient with acquired inhibitor during immune tolerance therapy according to modified Bonn-Malmö protocol.
    Schlabe S; van Bremen K; Goldmann G; Oldenburg J; Eis-Hübinger AM; Zeitler H; Spengler U
    Haemophilia; 2019 Mar; 25(2):e117-e120. PubMed ID: 30694010
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of hemophilia].
    Laurian Y
    Rev Prat; 1989 Dec; 39(30):2669-73. PubMed ID: 2515580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
    Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
    J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor concentrate prophylaxis for neonates with hemophilia.
    Buchanan GR
    J Pediatr Hematol Oncol; 1999; 21(4):254-6. PubMed ID: 10445886
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
    Zwahlen H; Beck EA
    Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
    Levine PH
    N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.